Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia

Contact Dermatitis

Volumn 53, Issue 4, 2005, Pages 214-218

  Ramirez De Knott, Haydee M ^a   Mccormick, Thomas S ^a   Do, Shaheen Oshtory ^a   Goodman, Wendy ^a   Ghannoum, Mahmoud A ^a,b   Cooper, Kevin D ^a   Nedorost, Susan T ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Center for Medical Mycology   (United States)

Author keywords

Atopic dermatitis; Atopy patch test; Dust mite; Protein contact dermatitis; Vulvodynia

Indexed keywords

ALLERGEN; CLIOQUINOL; CORTICOSTEROID; ECONAZOLE; LIDOCAINE; MICONAZOLE; NEOMYCIN; PYRROLE DERIVATIVE; TIXOCORTOL PIVALATE;

ADULT; ARTICLE; ATOPIC DERMATITIS; CANDIDA ALBICANS; CELL KILLING; CHRONICITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTACT ALLERGY; CONTROLLED STUDY; DERMATOPHAGOIDES; FEMALE; HUMAN; IDIOPATHIC DISEASE; NONHUMAN; PATCH TEST; SKIN ALLERGY; SKIN INFLAMMATION; SYMPTOMATOLOGY; ULTRAVIOLET RADIATION; VULVODYNIA;

ALLERGENS; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; FEMALE; HUMANS; PATCH TESTS; VULVAR DISEASES;

EID: 27144540570     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-1873.2005.00685.x     Document Type: Article

References (17)

1. Veasley C, Marinoff S. The evolution of vulvodynia terminology: clarifying the issue. In: National Vulvodynia Association News, N. V. Association (ed.): National Vulvodynia Association, Silver Springs, MD, USA, 2004: pp. 5-8.
2. Paavonen J. Vulvodynia - a complex syndrome of vulvar pain. Acta Obstet Gynecol Scand 1995: 74: 243-247.
3. Reed B D, Haefner H K, Punch M R, Roth R S, Gorenflo D W, Gillespie B W. Psychosocial and sexual functioning in women with vulvodynia and chronic pelvic pain. A comparative evaluation. J Reprod Med 2000: 45: 624-632.
4. Sonni L, Cattaneo A, De Marco A, De Magnis A, Carli P, Marabini S. Idiopathic vulvodynia. Clinical evaluation of the pain threshold with acetic acid solutions. J Reprod Med 1995: 40: 337-341.
5. Tympanidis P, Terenghi G, Dowd P. Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol 2003: 148: 1021-1027.
6. Gunter J, Brewer A, Tawfik O. Botulinum toxin a for vulvodynia: a case report. J Pain 2004: 5: 238-240.
7. Ek L, Theodorsson E. Tachykinins and calcitonin gene-related peptide in oxazolone-induced allergic contact dermatitis in mice. J Invest Dermatol 1990: 94: 761-763.
8. Marinoff S C, Turner M L. Hypersensitivity to vaginal candidiasis or treatment vehicles in the pathogenesis of minor vestibular gland syndrome. J Reprod Med 1986: 31: 796-799.
9. Marren P, Wojnarowska F, Powell S. Allergic contact dermatitis and vulvar dermatoses. Br J Dermatol 1992: 126: 52-56.
10. Petersen C S. Lack of contact allergy in consecutive women with vulvodynia. Contact Dermatitis 1997: 37: 46-47.9.
11. Farage M, Maibach H I. The vulvar epithelium differs from the skin: implications for cutaneous testing to address topical vulvar exposures. Contact Dermatitis 2004: 51: 201-209.
12. Edwards J N, Morris H B. Langerhans' cells and lymphocyte subsets in the female genital tract. Br J Obstet Gynaecol 1985: 92: 974-982.
13. Torii H, Yan Z, Hosoi J, Granstein R D. Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: further support for a functional relationship between Langerhans cells and epidermal nerves. J Invest Dermatol 1997: 109: 586-591.
14. Netea M G, Sutmuller R, Hermann C et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004: 172: 3712-3718.
15. Villamon E, Gozalbo D, Roig P, O'Connor J E, Ferrandiz M L, Fradelizi D, Gil M L. Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis. Microbes Infect 2004: 6: 542-548.
16. Bellocchio S, Montagnoli C, Bozza S et al. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004: 172: 3059-3069.
17. Tang N, Liu L, Kang K et al. Inhibition of monocytic interleukin-12 production by Candida albicans via selective activation of ERK mitogen-activated protein kinase. Infect Immun 2004: 72: 2513-2520.